INS and type 2 diabetes mellitus: KLK1 therapy has been studied in type 2 diabetes mellitus due to its role in the kallikrein‐kinin system, which influences insulin sensitization and glucose homeostasis by enhancing insulin‐induced glucose uptake, glucose transporter 4 translocation, and insulin receptor signaling.1